Lifebit

Lifebit

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17M

Overview

Lifebit has established itself as a leading provider of secure, federated data analysis platforms for the global genomics and precision medicine ecosystem. Founded in 2017, its technology allows researchers to run analyses on distributed, sensitive datasets (e.g., patient genomic data) where the data remains in its secure origin, addressing critical privacy, logistical, and scalability challenges. The company's platform is trusted by major national health initiatives and pharmaceutical partners, positioning it at the forefront of enabling large-scale, collaborative biomedical discovery.

OncologyRare DiseasesPrecision Medicine

Technology Platform

Lifebit Platform: A federated, cloud-based Trusted Research Environment (TRE) that enables secure analysis of distributed genomic and clinical data without moving the data. Features include zero data movement, instant federation and harmonization, built-in compliance, and scalable AI/ML tools.

Funding History

2
Total raised:$17M
Series A$14M
Seed$3M

Opportunities

The massive and growing volume of genomic data, coupled with stringent global data privacy laws, creates a strong demand for secure, federated analysis platforms.
Lifebit is well-positioned to capture market share from national precision medicine initiatives, pharmaceutical R&D programs, and large-scale research consortia that require collaborative analysis without data centralization.

Risk Factors

Lifebit faces competition from large cloud hyperscalers developing their own genomic data suites and must continuously execute complex deployments across client legacy systems.
Evolving data privacy regulations and potential client concentration in a few large government contracts also pose significant risks.

Competitive Landscape

Lifebit competes in the genomic data analysis and Trusted Research Environment market against large cloud providers (AWS, Google, Microsoft) offering broad-based genomic services and specialized bioinformatics software companies. Its key differentiator is its foundational 'zero data movement' federated architecture, which is uniquely suited for highly sensitive, regulated data collaborations where data sovereignty is paramount.